Literature DB >> 20589157

Effect of glycaemic control on glomerular filtration rate in diabetes mellitus patients.

Allen Meeme1, Hannington Kasozi.   

Abstract

BACKGROUND: Glomerular filtration rate (GFR) is a widely accepted parameter in assessing overall renal function. This study sought to assess the effect of glucose lowering on GFR in diabetic patients admitted for short term therapy at Mulago hospital.
METHODS: This was a descriptive study where consenting patients were consecutively recruited. Glomerular filtration rate was measured using creatinine clearance in 40 type I and II diabetes mellitus patients admitted on the basis of a glucometer reading of RBS >or= 300 mg/dl both at admission and discharge. Data was analyzed using a paired sample t-test and p-value set at 0.05 (95% CI).
RESULTS: A total of 40 patients were assessed. Their mean age was 49.8 years. 82.5% of them had type II DM while only 17.5% had type I DM. The average duration of disease was 7 years. GFR was found to decrease from 157.4 ml/min on admission to 86.4 ml/min at discharge (p=0.001). Random blood sugar levels decreased from 332.2mg/dl on admission to 119.8 mg/dl at discharge (p=0.000). CONCLUSION/RECOMMENDATION: Results imply that glycaemic control lowers the GFR in diabetic patients admitted for short term treatment. A reduction in GFR reflects reduction of hyperfiltration, a process that starts diabetic nephropathy. Good glycaemic control will go along way to delay onset of diabetic nephropathy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20589157      PMCID: PMC2890993     

Source DB:  PubMed          Journal:  Afr Health Sci        ISSN: 1680-6905            Impact factor:   0.927


  15 in total

Review 1.  Diabetic renal disease: from recent studies to improved clinical practice.

Authors:  C E Mogensen; M E Cooper
Journal:  Diabet Med       Date:  2004-01       Impact factor: 4.359

Review 2.  Predicting initiation and progression of chronic kidney disease: Developing renal risk scores.

Authors:  M W Taal; B M Brenner
Journal:  Kidney Int       Date:  2006-09-13       Impact factor: 10.612

Review 3.  Diabetic nephropathy: diagnosis, prevention, and treatment.

Authors:  Jorge L Gross; Mirela J de Azevedo; Sandra P Silveiro; Luís Henrique Canani; Maria Luiza Caramori; Themis Zelmanovitz
Journal:  Diabetes Care       Date:  2005-01       Impact factor: 19.112

Review 4.  Prediction of clinical diabetic nephropathy in IDDM patients. Alternatives to microalbuminuria?

Authors:  C E Mogensen
Journal:  Diabetes       Date:  1990-07       Impact factor: 9.461

Review 5.  Slowing progression along the renal disease continuum.

Authors:  Nelson P Kopyt
Journal:  J Am Osteopath Assoc       Date:  2005-04

Review 6.  Diabetic microvascular complications: can patients at risk be identified? A review.

Authors:  A Girach; D Manner; M Porta
Journal:  Int J Clin Pract       Date:  2006-11       Impact factor: 2.503

Review 7.  Glomerular hyperfiltration and the salt paradox in early [corrected] type 1 diabetes mellitus: a tubulo-centric view.

Authors:  Volker Vallon; Roland C Blantz; Scott Thomson
Journal:  J Am Soc Nephrol       Date:  2003-02       Impact factor: 10.121

Review 8.  Diabetes mellitus: its impact on women.

Authors:  K L Wishner
Journal:  Int J Fertil Menopausal Stud       Date:  1996 Mar-Apr

9.  Increased glomerular filtration rate as a predictor of diabetic nephropathy--an 8-year prospective study.

Authors:  S Rudberg; B Persson; G Dahlquist
Journal:  Kidney Int       Date:  1992-04       Impact factor: 10.612

10.  Random blood glucose estimation in type 2 diabetes: does it reflect overall glycaemic control?

Authors:  G V Gill; K J Hardy; A W Patrick; A Masterson
Journal:  Diabet Med       Date:  1994 Aug-Sep       Impact factor: 4.359

View more
  5 in total

Review 1.  Effect of diabetes mellitus on pharmacokinetic and pharmacodynamic properties of drugs.

Authors:  Miroslav Dostalek; Fatemeh Akhlaghi; Martina Puzanovova
Journal:  Clin Pharmacokinet       Date:  2012-08-01       Impact factor: 6.447

2.  Gas1 expression in parietal cells of Bowman's capsule in experimental diabetic nephropathy.

Authors:  Brenda I Luna-Antonio; Rafael Rodriguez-Muñoz; Carmen Namorado-Tonix; Paula Vergara; Jose Segovia; Jose L Reyes
Journal:  Histochem Cell Biol       Date:  2017-03-18       Impact factor: 4.304

3.  Comparison of pharmacokinetic parameters of ranolazine between diabetic and non-diabetic rats.

Authors:  Habibeh Mashayekhi-Sardoo; Hossein Kamali; Soghra Mehri; Amirhossein Sahebkar; Mohsen Imenshahidi; Amir Hooshang Mohammadpour
Journal:  Iran J Basic Med Sci       Date:  2022-07       Impact factor: 2.532

4.  Prevalence and associated risk factors of chronic kidney disease: A case study within SIME clinics in Quito, Ecuador 2019-2021.

Authors:  Lucía Eguiguren-Jiménez; Joshua Miles; Jaime Ocampo; Jeanette Mary Andrade
Journal:  Front Med (Lausanne)       Date:  2022-08-19

5.  Prevalence of diabetic nephropathy in Type 2 Diabetes Mellitus in rural communities of Guanajuato, Mexico. Effect after 6 months of Telmisartan treatment.

Authors:  Priscyla Zenteno-Castillo; Daniela Beatriz Muñoz-López; Benjamín Merino-Reyes; Ángel Vega-Sánchez; Monica Preciado-Puga; Ana Lilia González-Yebra; Carlos Kornhauser
Journal:  J Clin Transl Endocrinol       Date:  2015-08-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.